The START Center for Cancer Research Revenue and Competitors
Employee Data
- The START Center for Cancer Research has 107 Employees.
- The START Center for Cancer Research grew their employee count by 234% last year.
The START Center for Cancer Research's People
Name | Title | Email/Phone |
---|---|---|
1 | Global Chief HR Officer | Reveal Email/Phone |
2 | Chief Growth Officer | Reveal Email/Phone |
3 | Global Chief Medical Officer | Reveal Email/Phone |
4 | Chief Development Officer (CDO) | Reveal Email/Phone |
5 | General Counsel, Chief Legal Officer, & Corporate Secretary | Reveal Email/Phone |
6 | Chief Compliance Officer | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | SVP Sales | Reveal Email/Phone |
9 | VP Human Resources | Reveal Email/Phone |
10 | VP Compliance | Reveal Email/Phone |
The START Center for Cancer Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 13 | 44% | N/A | N/A |
#2 | $14.9M | 73 | -8% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 5 | -37% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 51 | 31% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $1.6M | 9 | 13% | N/A | N/A |
#10 | $16.3M | 80 | -9% | N/A | N/A |
What Is The START Center for Cancer Research?
Deeply rooted in community oncology centers globally, the START Center for Cancer Research (\START\) provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,300 early phase clinical trials, including for 45 therapies that have gained FDA/EMA approval. Founded in Texas in 2007, START today boasts 25 Principal Investigators (PIs) across its worldwide clinical trial sites. With over 100,000+ square feet of world-class research facilities, START offers patients comprehensive treatment plans that include multi-specialty services, genetic profiling of tumors, targeted therapies, state-of-the-art treatment technology, and advanced access to clinical research options. START is committed to accelerating passage from trials to treatments, and to delivering hope to patients, families, and physicians around the world.
keywords:N/AN/A
Total Funding
107
Number of Employees
N/A
Revenue (est)
234%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $32.6M | 107 | 24% | N/A |
#2 | $23.5M | 107 | 6% | N/A |
#3 | $15M | 107 | -8% | $91.4M |
#4 | $19.6M | 107 | 15% | N/A |
#5 | $21.2M | 107 | -10% | N/A |